| Specialty Retail Industry | Consumer Discretionary Sector | Hans-Georg Feldmeier CEO | XDUS Exchange | DE000A2GS5D8 ISIN |
| DE Country | 3,610 Employees | 29 Jun 2026 Last Dividend | - Last Split | - IPO Date |
Dermapharm Holding SE is a distinguished entity in the pharmaceutical sector, specializing in the manufacture and distribution of off-patent branded pharmaceutical products predominantly in Germany. Established in 1991 with its headquarters in Grünwald, Germany, the company operates as a pivotal part of Themis Beteiligungs-AG. Dermapharm distinguishes itself through its operation across three core segments: Branded Pharmaceuticals and Other Healthcare Products, Parallel Import Business, and Herbal Extracts. This diversified approach enables Dermapharm to cater to a broad spectrum of healthcare needs, ensuring a comprehensive portfolio that addresses various medical and health-related concerns.